Stock Forecast Chart
Stock Price Prediction Summary
Forecast Score Based on 2 Weeks
Based on our forecast, the price of RGLS will decline by -1.20% over the next 2 Weeks and hit $8.06 by Wednesday, July 9, 2025. In that time frame, RGLS's share price is expected to range between $7.96 and $8.16.
BearishAverageBullish| Date | Predicted Lower | Predicted | Predicted Upper |
|---|---|---|---|
| Jul 9, 2025 | 7.96 | 8.06 | 8.18 |
| Jul 8, 2025 | 7.99 | 8.09 | 8.19 |
| Jul 7, 2025 | 8.01 | 8.10 | 8.19 |
| Jul 4, 2025 | 7.94 | 8.02 | 8.11 |
| Jul 3, 2025 | 7.99 | 8.07 | 8.16 |
| Jul 2, 2025 | 8.02 | 8.09 | 8.17 |
| Jul 1, 2025 | 8.04 | 8.12 | 8.20 |
| Jun 30, 2025 | 8.05 | 8.13 | 8.20 |
| Jun 27, 2025 | 7.97 | 8.05 | 8.13 |
| Jun 26, 2025 | 8.02 | 8.10 | 8.18 |
RGLS shares remained flat 0 in Wednesday, June 25, 2025's trading session, starting and closing at a previous close of $8.16 to move at $8.16. The stock demonstrated notable intraday movement (see RGLS's key stats for a full breakdown), fluctuating between $8.16 and $8.16, a 0 trading range. While recent weeks have seen some volatility, RGLS has managed to secure a +0.12% gain over the past 2 weeks. The neutral price movement was accompanied by decreased trading volume, with approximately 0 shares changing hands, 9.34M fewer than the previous session. This amounted to $0.00 in total market activity.
Will RGLS Continue Its Upward Trend?
According to analyst ratings and projections for RGLS, Regulus Therapeutics Inc. shares are anticipated to increase by +0.24%, potentially reaching $8.18 per share by July 9, 2025. Short-term technical indicators currently suggest a neutral sentiment for RGLS. For deeper insights, view our sentiment analysis on AAPL covering social and institutional perspectives. However, the stock has recorded 15 positive trading days within the past 30 sessions. Based on the RGLS stock forecast, now is a good time to buy RGLS stock because its current trading price is +1.21% above our predicted value, hinting at a possible undervaluation. For deeper insights, view our sentiment analysis on RGLS covering social and institutional perspectives.
RGLS Technical Momentum: Overbought, Oversold, or Neutral?
An analysis of Relative Strength Index (RSI) indicators provides insight into RGLS's momentum. Short-term RSIs (9, 14, and 20-day figures ranging from 57.99% to 73.02%) suggest the stock is showing bullish momentum with some volatility. The 50-day RSI, at 77.30%, indicates significant medium-term strength. Additionally, the 100-day RSI, at 72.85%, indicates a bearish outlook for the long term. Insights into RGLS's shareholder base show how institutional investors are positioning themselves during these momentum shifts
Regulus Therapeutics Short-Term Forecasts
RGLS Forecast For Next 5 Days
Our algorithm anticipates Regulus Therapeutics (RGLS) stock could hit $8.28 by Jul 18, 2025. This represents a +1.52% fall from today's price, following a -0.49% change over the past five days.
RGLS Forecast For Next 30 Days
Based on analysis of market trends, the outlook for Regulus Therapeutics Inc. (RGLS) stock over the next 30 days is largely negative. Price forecasts suggest an average target of $7.92, which would mean a -2.94% decrease from the current price of $8.16. Projections for this period range from a high of $9.25 to a low of $6.54.
RGLS Forecast For Next 90 Days
Our proprietary market analysis suggests predictions for Regulus Therapeutics's price over the next three months point to a rise. RGLS stock is expected to peak at $26.91 on Apr 21, 2026 after potentially dipping to $7.32 on Feb 16, 2026. On average, RGLS is likely to trade around $17.06 in the coming 90 days.
Regulus Therapeutics Stock Forecast 2025
Based on our predictive models, Regulus Therapeutics (RGLS) is expected to trade between $7.32 and $50.88 throughout 2026. This would result in an average price of $25.53, potentially offering investors a +212.87% return from current levels.
Regulus Therapeutics Inc. Monthly Forecast 2025–2026
July 2025
According to our latest forecast models, Regulus Therapeutics Inc. (RGLS) is positioned to show a strong performance in July 2025. The price is predicted to move between $28.30 and $31.39, settling at an average of $29.89. This could translate to a +266.30% gain.
August 2025
Based on current market signals, Regulus Therapeutics Inc. is projected to trend august 2025. We forecast a trading range from $25.98 to $30.66, with a likely average price of $27.72. Investors could expect a potential return of +239.71%.
September 2025
Our predictive algorithms indicate Regulus Therapeutics Inc. stock may see a shift in September 2025. The expected range spans $28.06–$43.58, with an average target of $31.46. This represents a positive outlook and a possible gain of +285.54%.
October 2025
Analyzing established trends, Regulus Therapeutics Inc. looks set to move in October 2025. Projections place the stock between $33.42 and $45.10, averaging around $37.71. This suggests a +362.13% gain from current levels.
November 2025
Market indicators suggest Regulus Therapeutics Inc. could experience notable changes during November 2025. Prices could fluctuate within $26.94 to $33.33, with a midpoint forecast of $29.04. The stock might deliver a +255.88% gain.
December 2025
Forecasting for December 2025, models estimate that Regulus Therapeutics Inc. may undergo key fluctuations. If trends hold, the stock might trade between $22.40 and $28.63, averaging $24.16. This signals a positive trajectory with potential returns around +196.08%.
January 2026
According to our latest forecast models, Regulus Therapeutics Inc. (RGLS) is positioned to show a strong performance in January 2026. The price is predicted to move between $10.26 and $22.99, settling at an average of $14.81. This could translate to a +81.50% gain.
February 2026
Based on current market signals, Regulus Therapeutics Inc. is projected to trend february 2026. We forecast a trading range from $7.32 to $24.35, with a likely average price of $11.81. Investors could expect a potential return of +44.73%.
March 2026
Our predictive algorithms indicate Regulus Therapeutics Inc. stock may see a shift in March 2026. The expected range spans $20.73–$25.11, with an average target of $21.62. This represents a positive outlook and a possible gain of +164.95%.
April 2026
Analyzing established trends, Regulus Therapeutics Inc. looks set to move in April 2026. Projections place the stock between $19.09 and $40.17, averaging around $23.74. This suggests a +190.93% gain from current levels.
May 2026
Market indicators suggest Regulus Therapeutics Inc. could experience notable changes during May 2026. Prices could fluctuate within $39.56 to $50.88, with a midpoint forecast of $42.68. The stock might deliver a +423.04% gain.
June 2026
Forecasting for June 2026, models estimate that Regulus Therapeutics Inc. may undergo key fluctuations. If trends hold, the stock might trade between $40.03 and $48.45, averaging $40.01. This signals a positive trajectory with potential returns around +390.32%.
RGLS's history of dividends and stock splits also plays a role in long-term investor confidence.